tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Boston Scientific Announces Executive Retirement Plan Update

Story Highlights
  • Jeffrey B. Mirviss will retire from his executive role at Boston Scientific on December 1, 2025.
  • He will remain as a senior advisor until February 27, 2026, with a prorated salary and a retirement agreement.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Boston Scientific Announces Executive Retirement Plan Update

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Boston Scientific ( (BSX) ) has shared an announcement.

On August 29, 2025, Boston Scientific announced that Jeffrey B. Mirviss will retire from his position as Executive Vice President and President of Peripheral Interventions, effective December 1, 2025. He will continue as a senior advisor until February 27, 2026, receiving a prorated base salary. The company plans to enter into a Retirement Agreement with Mr. Mirviss, ensuring he receives benefits consistent with the company’s Executive Retirement Plan and other incentive programs.

The most recent analyst rating on (BSX) stock is a Buy with a $116.00 price target. To see the full list of analyst forecasts on Boston Scientific stock, see the BSX Stock Forecast page.

Spark’s Take on BSX Stock

According to Spark, TipRanks’ AI Analyst, BSX is a Outperform.

Boston Scientific’s strong financial performance and positive earnings call outlook are significant strengths, driving the overall score. However, the high valuation and neutral technical indicators temper the score. The company’s strategic growth initiatives and robust segment performance support a positive long-term outlook, despite some near-term valuation concerns.

To see Spark’s full report on BSX stock, click here.

More about Boston Scientific

Boston Scientific is a leading company in the medical device industry, specializing in the development and manufacturing of a wide range of products used in interventional medical specialties. The company focuses on providing innovative solutions for various medical conditions, enhancing patient care and improving clinical outcomes.

Average Trading Volume: 7,221,032

Technical Sentiment Signal: Buy

Current Market Cap: $158B

For detailed information about BSX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1